Hanson & Doremus Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.8M Sell
48,578
-1,708
-3% -$138K 0.39% 39
2026
Q1
$4.36M Buy
50,286
+3,973
+9% +$381K 0.5% 35
2025
Q4
$4.45M Sell
46,313
-385
-0.8% -$37.4K 0.53% 32
2025
Q3
$4.45M Sell
46,698
-3,154
-6% -$290K 0.56% 31
2025
Q2
$4.35M Sell
49,852
-205
-0.4% -$17.4K 0.58% 31
2025
Q1
$4.5M Buy
50,057
+1,253
+3% +$112K 0.66% 28
2024
Q4
$3.9M Buy
48,804
+639
+1% +$55.3K 0.61% 29
2024
Q3
$4.34M Buy
48,165
+552
+1% +$46.4K 0.69% 27
2024
Q2
$3.75M Buy
47,613
+1,549
+3% +$127K 0.63% 28
2024
Q1
$4.01M Buy
46,064
+2,966
+7% +$253K 0.69% 27
2023
Q4
$3.55M Buy
43,098
+335
+0.8% +$25.5K 0.67% 29
2023
Q3
$3.35M Buy
42,763
+3,033
+8% +$254K 0.69% 29
2023
Q2
$3.5M Buy
39,730
+5,451
+16% +$469K 0.73% 24
2023
Q1
$2.76M Buy
34,279
+2,815
+9% +$229K 0.61% 31
2022
Q4
$2.44M Buy
31,464
+4,290
+16% +$348K 0.53% 42
2022
Q3
$2.19M Buy
27,174
+4,846
+22% +$436K 0.57% 38
2022
Q2
$2M Buy
22,328
+2,009
+10% +$204K 0.49% 41
2022
Q1
$2.25M Buy
20,319
+1,823
+10% +$193K 0.49% 41
2021
Q4
$1.91M Buy
18,496
+897
+5% +$104K 0.41% 49
2021
Q3
$2.21M Buy
17,599
+1,556
+10% +$201K 0.51% 38
2021
Q2
$1.67M Sell
16,043
-499
-3% -$62.7K 0.5% 43
2021
Q1
$1.95M Sell
16,542
-710
-4% -$83.2K 0.45% 46
2020
Q4
$2.02M Buy
17,252
+1,209
+8% +$133K 0.5% 41
2020
Q3
$1.67M Buy
16,043
+1,394
+10% +$140K 0.5% 43
2020
Q2
$1.34M Sell
14,649
-274
-2% -$26.3K 0.43% 46
2020
Q1
$1.35M Buy
14,923
+1,237
+9% +$132K 0.46% 46
2019
Q4
$1.55M Sell
13,686
-64
-0.5% -$7.02K 0.45% 52
2019
Q3
$1.49M Sell
13,750
-411
-3% -$42.9K 0.46% 49
2019
Q2
$1.38M Sell
14,161
-255
-2% -$23.3K 0.44% 47
2019
Q1
$1.31M Buy
14,416
+128
+0.9% +$11.5K 0.43% 54
2018
Q4
$1.3M Sell
14,288
-319
-2% -$29.8K 0.47% 49
2018
Q3
$1.44M Sell
14,607
-11
-0.1% -$1.02K 0.45% 53
2018
Q2
$1.25M Sell
14,618
-480
-3% -$40.1K 0.41% 62
2018
Q1
$1.21M Buy
15,098
+20
+0.1% +$1.65K 0.38% 67
2017
Q4
$1.22M Sell
15,078
-60
-0.4% -$4.8K 0.41% 66
2017
Q3
$1.18M Sell
15,138
-125
-0.8% -$10.4K 0.41% 66
2017
Q2
$1.35M Sell
15,263
-190
-1% -$16K 0.5% 57
2017
Q1
$1.25M Sell
15,453
-270
-2% -$21.1K 0.5% 60
2016
Q4
$1.12M Sell
15,723
-185
-1% -$14.5K 0.48% 62
2016
Q3
$1.37M Sell
15,908
-165
-1% -$14.4K 0.64% 47
2016
Q2
$1.4M Sell
16,073
-620
-4% -$50.1K 0.63% 43
2016
Q1
$1.25M Sell
16,693
-775
-4% -$58.4K 0.57% 48
2015
Q4
$1.34M Buy
17,468
+70
+0.4% +$5.27K 0.61% 45
2015
Q3
$1.17M Sell
17,398
-976
-5% -$71.9K 0.56% 51
2015
Q2
$1.36M Sell
18,374
-470
-2% -$35.9K 0.58% 50
2015
Q1
$1.47M Sell
18,844
-1,244
-6% -$94.3K 0.62% 46
2014
Q4
$1.45M Sell
20,088
-564
-3% -$39.2K 0.62% 46
2014
Q3
$1.28M Sell
20,652
-80
-0.4% -$5.09K 0.58% 55
2014
Q2
$1.32M Hold
20,732
0.61% 51
2014
Q1
$1.28M Sell
20,732
-874
-4% -$50.9K 0.6% 52
2013
Q4
$1.24M Sell
21,606
-6,521
-23% -$370K 0.6% 53
2013
Q3
$1.5M Sell
28,127
-440
-2% -$23.7K 0.76% 40
2013
Q2
$1.47M Buy
+28,567
New +$1.41M 0.8% 36

Other funds holding MDT

Hanson & Doremus Investment Management's MDT Position: Q2 2026 in Review

Hanson & Doremus Investment Management reduced its Medtronic (MDT) stake by 3.4% in Q2 2026, selling an estimated $138K and leaving 48,578 shares worth $3.8M. The position accounts for 0.39% of the portfolio, ranked #39.

Hanson & Doremus Investment Management first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.5M in Q1 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Hanson & Doremus Investment Management held 48,578 shares of Medtronic worth $3.8M as of Q2 2026.
  • Hanson & Doremus Investment Management sold 1,708 Medtronic shares in Q2 2026, an estimated $138K.
  • Medtronic made up 0.39% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #39 holding.
  • Hanson & Doremus Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Hanson & Doremus Investment Management's Medtronic position peaked at $4.5M in Q1 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.